DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,412 filers reported holding DANAHER CORPORATION in Q3 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $5,297,000 | +20.7% | 19,738 | +1.2% | 0.06% | +23.5% |
| Q1 2021 | $4,390,000 | +2.1% | 19,504 | +0.8% | 0.05% | -1.9% |
| Q4 2020 | $4,299,000 | +6.6% | 19,353 | +3.3% | 0.05% | -3.7% |
| Q3 2020 | $4,033,000 | +4.5% | 18,726 | -14.2% | 0.05% | 0.0% |
| Q2 2020 | $3,859,000 | +18.7% | 21,821 | -7.1% | 0.05% | +3.8% |
| Q1 2020 | $3,251,000 | -21.1% | 23,484 | -11.6% | 0.05% | +26.8% |
| Q4 2019 | $4,121,000 | +12.1% | 26,565 | +4.4% | 0.04% | +2.5% |
| Q3 2019 | $3,676,000 | -0.9% | 25,447 | -1.9% | 0.04% | 0.0% |
| Q2 2019 | $3,709,000 | -0.6% | 25,947 | -8.1% | 0.04% | -2.4% |
| Q1 2019 | $3,730,000 | +42.4% | 28,247 | +11.2% | 0.04% | +20.6% |
| Q4 2018 | $2,619,000 | -6.5% | 25,391 | -1.5% | 0.03% | +25.9% |
| Q3 2018 | $2,800,000 | +2.2% | 25,769 | -7.2% | 0.03% | 0.0% |
| Q2 2018 | $2,740,000 | +0.8% | 27,769 | +0.1% | 0.03% | -3.6% |
| Q1 2018 | $2,717,000 | +1.5% | 27,749 | -3.8% | 0.03% | +12.0% |
| Q4 2017 | $2,678,000 | +11.5% | 28,849 | +3.0% | 0.02% | +31.6% |
| Q3 2017 | $2,402,000 | +3.9% | 27,998 | +2.2% | 0.02% | -5.0% |
| Q2 2017 | $2,312,000 | +3.5% | 27,398 | +5.0% | 0.02% | +5.3% |
| Q1 2017 | $2,233,000 | +119.8% | 26,105 | +99.9% | 0.02% | +137.5% |
| Q4 2016 | $1,016,000 | -0.6% | 13,057 | +0.1% | 0.01% | 0.0% |
| Q3 2016 | $1,022,000 | -22.3% | 13,039 | +0.1% | 0.01% | -27.3% |
| Q2 2016 | $1,316,000 | +4.4% | 13,029 | -2.0% | 0.01% | -8.3% |
| Q1 2016 | $1,261,000 | +10.4% | 13,296 | +8.1% | 0.01% | +9.1% |
| Q4 2015 | $1,142,000 | +4.8% | 12,296 | -3.9% | 0.01% | 0.0% |
| Q3 2015 | $1,090,000 | -0.5% | 12,791 | 0.0% | 0.01% | -21.4% |
| Q2 2015 | $1,095,000 | -74.1% | 12,791 | -74.3% | 0.01% | -70.8% |
| Q1 2015 | $4,225,000 | +26.4% | 49,791 | +27.7% | 0.05% | +26.3% |
| Q4 2014 | $3,342,000 | +97.3% | 38,991 | +74.9% | 0.04% | -15.6% |
| Q3 2014 | $1,694,000 | -4.3% | 22,291 | -0.9% | 0.04% | -4.3% |
| Q2 2014 | $1,771,000 | +68.2% | 22,491 | +60.5% | 0.05% | +46.9% |
| Q1 2014 | $1,053,000 | -2.7% | 14,017 | 0.0% | 0.03% | -22.0% |
| Q4 2013 | $1,082,000 | -0.1% | 14,017 | -10.2% | 0.04% | -12.8% |
| Q3 2013 | $1,083,000 | +20.9% | 15,617 | +14.8% | 0.05% | +51.6% |
| Q2 2013 | $896,000 | – | 13,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |